Form 8-K - Current report:
SEC Accession No. 0000950170-24-125455
Filing Date
2024-11-12
Accepted
2024-11-12 16:18:09
Documents
14
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20241112.htm   iXBRL 8-K 41825
2 EX-99.1 lyra-ex99_1.htm EX-99.1 29372
3 GRAPHIC img93999977_0.jpg GRAPHIC 145703
4 GRAPHIC img93999977_1.jpg GRAPHIC 122763
  Complete submission text file 0000950170-24-125455.txt   561267

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20241112.xsd EX-101.SCH 24869
16 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20241112_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 241448492
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)